Pacific Biosciences Of California reported $896.22M in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Accelerate Diagnostics AXDX:US 116.08M 8.02M
Agilent A:US $ 2905M 175M
Bruker BRKR:US $ 1216.4M 117.8M
Danaher DHR:US $ 21778M 398M
Fluidigm FLDM:US $ 100.03M 28.98M
General Electric GE:US $ 33634M 1551M
Illumina ILMN:US $ 1740M 45M
Myriad Genetics MYGN:US $ 0M 0M
Nanostring Technologies NSTG:US $ 225.51M 0.37M
Pacific Biosciences Of California PACB:US $ 896.22M 0.15M
Perkinelmer PKI:US $ 4867.71M 116.27M
Quidel QDEL:US $ 0M 0M
Thermo Fisher Scientific TMO:US $ 33255M 1615M
Waters WAT:US $ 1444.12M 69.75M